Serveur d'exploration sur la rapamycine et les champignons - Exploration (Accueil)

Index « Titre (en) » - entrée « new »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
neutrophils < new < newborn  Facettes :

List of bibliographic references indexed by new

Number of relevant bibliographic references: 37.
[0-20] [0 - 20][0 - 37][20-36][20-40]
Ident.Authors (with country if any)Title
000134 (2020) Kumari Asha [États-Unis] ; Natalie Balfe [États-Unis] ; Neelam Sharma-Walia [États-Unis]Concurrent Control of the Kaposi's Sarcoma-Associated Herpesvirus Life Cycle through Chromatin Modulation and Host Hedgehog Signaling: a New Prospect for the Therapeutic Potential of Lipoxin A4.
000163 (2020) Yen-Lin Chen [Taïwan] ; I-Chuan Yen [Taïwan] ; Kuen-Tze Lin [Taïwan] ; Feng-Yi Lai [Taïwan] ; Shih-Yu Lee [Taïwan]4-Acetylantrocamol LT3, a New Ubiquinone from Antrodia cinnamomea, Inhibits Hepatocellular Carcinoma HepG2 Cell Growth by Targeting YAP/TAZ, mTOR, and WNT/β-Catenin Signaling.
000173 (2019) Nadia Vazirpanah [Oman] ; Andrea Ottria [Pays-Bas] ; Maarten Van Der Linden [Pays-Bas] ; Catharina G K. Wichers [Pays-Bas] ; Mark Schuiveling [Pays-Bas] ; Ellen Van Lochem [Pays-Bas] ; Amanda Phipps-Green [Nouvelle-Zélande] ; Tony Merriman [Nouvelle-Zélande] ; Maili Zimmermann [Pays-Bas] ; Matthijs Jansen [Pays-Bas] ; Timothy R D J. Radstake [Pays-Bas] ; Jasper C A. Broen [Pays-Bas]mTOR inhibition by metformin impacts monosodium urate crystal-induced inflammation and cell death in gout: a prelude to a new add-on therapy?
000349 (2019) Hanzada Mohamed El Maghrabi [Égypte] ; Ahmed Yahia Elmowafy [Égypte] ; Ayman Fathi Refaie [Égypte] ; Mohammed Adel Elbasiony [Égypte] ; Gamal Elsayed Shiha [Égypte] ; Lionel Rostaing [France] ; Mohamed Adel Bakr [Égypte]Efficacy and safety of the new antiviral agents for the treatment of hepatitis C virus infection in Egyptian renal transplant recipients.
000538 (2018) Alfonso H. Santos [États-Unis] ; Chao Chen [États-Unis] ; Michael J. Casey [États-Unis] ; Karl L. Womer [États-Unis] ; Xuerong Wen [États-Unis]New-onset diabetes after kidney transplantation: can the risk be modified by choosing immunosuppression regimen based on pretransplant viral serology?
000543 (2018) Alain G. Verstraete [Belgique] ; Raül Rigo-Bonnin [Espagne] ; Pierre Wallemacq [Belgique] ; Michael Vogeser [Allemagne] ; Andre Schuetzenmeister ; Christian Schmiedel ; Maria Shipkova [Allemagne]Multicenter Evaluation of a New Electrochemiluminescence Immunoassay for Everolimus Concentrations in Whole Blood.
000594 (2018) Jing Li [République populaire de Chine] ; Chuxiong Zeng [République populaire de Chine] ; Beishi Zheng [République populaire de Chine] ; Chun Liu [République populaire de Chine] ; Min Tang [République populaire de Chine] ; Yan Jiang [République populaire de Chine] ; Yizhong Chang [République populaire de Chine] ; Weiping Song [République populaire de Chine] ; Yingxin Wang [République populaire de Chine] ; Changqing Yang [République populaire de Chine]HMGB1-induced autophagy facilitates hepatic stellate cells activation: a new pathway in liver fibrosis.
000596 (2018) Mohamed H. Noureldein [Liban] ; Assaad A. Eid [Liban]Gut microbiota and mTOR signaling: Insight on a new pathophysiological interaction.
000673 (2018) Wakana Saso [Japon] ; Senko Tsukuda [Japon] ; Hirofumi Ohashi [Japon] ; Kento Fukano [Japon] ; Ryo Morishita [Japon] ; Satoko Matsunaga [Japon] ; Mio Ohki [Japon] ; Akihide Ryo [Japon] ; Sam-Yong Park [Japon] ; Ryosuke Suzuki [Japon] ; Hideki Aizaki [Japon] ; Masamichi Muramatsu [Japon] ; Camille Sureau [France] ; Takaji Wakita [Japon] ; Tetsuro Matano [Japon] ; Koichi Watashi [Japon]A new strategy to identify hepatitis B virus entry inhibitors by AlphaScreen technology targeting the envelope-receptor interaction.
000788 (2017) Neil SavageNew tricks from old dogs join the fight against ageing.
000989 (2016) Min-Jae Kang [Corée du Sud] ; Keun Ki Kim [Corée du Sud] ; Byoung Yil Son [Corée du Sud] ; Soo-Wan Nam [Corée du Sud] ; Pyung-Gyun Shin [Corée du Sud] ; Gun-Do Kim [Corée du Sud]The Anti-Adipogenic Activity of a New Cultivar, Pleurotus eryngii var. ferulae 'Beesan No. 2', through Down-Regulation of PPAR γ and C/EBP α in 3T3-L1 Cells.
000A59 (2016) S. Mas [Espagne] ; P. Gass [Espagne] ; D. Boloc [Espagne] ; N. Rodriguez [Espagne] ; F. Mármol [Espagne] ; J. Sánchez [Espagne] ; M. Bernardo [Espagne] ; A. Lafuente [Espagne]Network analysis of gene expression in mice provides new evidence of involvement of the mTOR pathway in antipsychotic-induced extrapyramidal symptoms.
000C17 (2015) Christoph Aderhold [Allemagne] ; Anne Faber [Allemagne] ; Claudia Umbreit [Allemagne] ; Anja Chakraborty [Allemagne] ; Andre Bockmayer [Allemagne] ; Richard Birk [Allemagne] ; Jörg Ulrich Sommer [Allemagne] ; Karl Hörmann [Allemagne] ; Johannes David Schultz [Allemagne]Small molecules alter VEGFR and PTEN expression in HPV-positive and -negative SCC: new hope for targeted-therapy.
000D04 (2015) Mohamed H. Abbas [Égypte] ; Mabrouk I. Ismail ; Salem A. El Deeb ; Ayman M. Nagib ; Nabil M. Hassan ; Ayman F. Refaie ; Hanzada M. El Maghrabi ; Ahmed A. Denewar ; Mohamed A. BakrEffect of pretransplant hepatitis C virus on the development of new-onset diabetes mellitus after transplant in Egyptian living-donor renal allotransplant recipients at Mansoura Urology and Nephrology Center.
000D59 (2015) Konrad Klinghammer [Allemagne] ; Jan-Dirk Raguse ; Thomas Plath ; Andreas E. Albers ; Korinna Joehrens ; Andre Zakarneh ; Bernadette Brzezicha ; Annika Wulf-Goldenberg ; Ulrich Keilholz ; Jens Hoffmann ; Iduna FichtnerA comprehensively characterized large panel of head and neck cancer patient-derived xenografts identifies the mTOR inhibitor everolimus as potential new treatment option.
000E02 (2014) Ronit Weisman [Israël] ; Adiel Cohen [Israël] ; Susan M. Gasser [Israël]TORC2-a new player in genome stability.
001085 (2013) Caleb Mckinney [États-Unis] ; Dong Yu ; Ian MohrA new role for the cellular PABP repressor Paip2 as an innate restriction factor capable of limiting productive cytomegalovirus replication.
001153 (2012) A. Amedei [Italie] ; M M D'EliosNew therapeutic approaches by using microorganism-derived compounds.
001236 (2011) A. Dupuy [France][What's new in dermatological therapy?].
001295 (2011) Annemieke A. Michels [Suisse]MAF1: a new target of mTORC1.
001329 (2011) Rui Gong [République populaire de Chine] ; Li Li ; Yi Liu ; Ping Wang ; Huirong Yang ; Ling Wang ; Jingdong Cheng ; Kun-Liang Guan ; Yanhui XuCrystal structure of the Gtr1p-Gtr2p complex reveals new insights into the amino acid-induced TORC1 activation.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/RapamycinFungusV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "new" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "new" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    RapamycinFungusV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    new
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Thu Nov 19 21:55:41 2020. Site generation: Thu Nov 19 22:00:39 2020